|
2025-03-28 |
2025-03-27 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
6,251
-1.2%
12.40
USD 77,512
|
6,251
-1.2%
|
12.40
|
USD 77,512
|
|
|
2025-03-20 |
2025-03-18 |
PS
Planned sale
|
Yamagishi-Dressler Tomoko
Chief Marketing Officer
Officer
|
4,536
-4.5%
13.26
USD 60,125
|
4,536
-4.5%
|
13.26
|
USD 60,125
|
|
|
2025-03-20 |
2025-03-18 |
PS
Planned sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
8,996
-4.9%
13.26
USD 119,243
|
8,996
-4.9%
|
13.26
|
USD 119,243
|
|
|
2025-03-20 |
2025-03-18 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
27,904
-7.1%
13.26
USD 369,868
|
27,904
-7.1%
|
13.26
|
USD 369,868
|
|
|
2025-03-20 |
2025-03-18 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
103,376
-16.7%
13.26
USD 1,370,249
|
103,376
-16.7%
|
13.26
|
USD 1,370,249
|
|
|
2025-03-14 |
2025-03-12 |
S
Sale
|
Parschauer Karah Herdman
Non-Executive Director
|
12,888
-28.6%
12.99
USD 167,465
|
12,888
-28.6%
|
12.99
|
USD 167,465
|
|
|
2024-12-26 |
2024-12-23 |
PS
Planned sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
1,586
-1.1%
10.85
USD 17,211
|
1,586
-1.1%
|
10.85
|
USD 17,211
|
|
|
2024-12-26 |
2024-12-23 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
10,502
-2.0%
10.85
USD 113,967
|
10,502
-2.0%
|
10.85
|
USD 113,967
|
|
|
2024-12-26 |
2024-12-23 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
2,252
-0.6%
10.85
USD 24,438
|
2,252
-0.6%
|
10.85
|
USD 24,438
|
|
|
2024-09-06 |
2024-09-06 |
S
Sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
3,276
-2.2%
14.98
USD 49,074
|
3,276
-2.2%
|
14.98
|
USD 49,074
|
|
|
2024-09-04 |
2024-08-30 |
S
Sale
|
Yamagishi-Dressler Tomoko
Chief Marketing Officer
Officer
|
5,631
-6.4%
15.85
USD 89,251
|
5,631
-6.4%
|
15.85
|
USD 89,251
|
|
|
2024-06-06 |
2024-06-06 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
175,940
-24.8%
12.59
USD 2,214,486
|
175,940
-24.8%
|
12.59
|
USD 2,214,486
|
|
|
2024-06-06 |
2024-06-05 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
155,278
-22.5%
12.92
USD 2,006,456
|
155,278
-22.5%
|
12.92
|
USD 2,006,456
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
140,214
-20.8%
12.73
USD 1,784,686
|
140,214
-20.8%
|
12.73
|
USD 1,784,686
|
|
|
2024-06-05 |
2024-06-03 |
S
Sale
|
Malik Vikram
Non-Executive Director
|
7,500
-3.0%
12.96
USD 97,203
|
7,500
-3.0%
|
12.96
|
USD 97,203
|
|
|
2024-05-15 |
2024-05-14 |
S
Sale
|
GILL DAVID N
Non-Executive Director
|
6,718
-16.5%
12.60
USD 84,654
|
6,718
-16.5%
|
12.60
|
USD 84,654
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Malik Vikram
Non-Executive Director
|
28,000
-9.9%
12.93
USD 362,012
|
28,000
-9.9%
|
12.93
|
USD 362,012
|
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
GILL DAVID N
Non-Executive Director
|
3,643
-8.2%
12.72
USD 46,356
|
3,643
-8.2%
|
12.72
|
USD 46,356
|
|
|
2024-05-14 |
2024-05-10 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
16,051
-2.3%
12.72
USD 204,127
|
16,051
-2.3%
|
12.72
|
USD 204,127
|
|
|
2024-05-14 |
2024-05-10 |
S
Sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
2,423
-1.6%
12.72
USD 30,814
|
2,423
-1.6%
|
12.72
|
USD 30,814
|
|
|
2024-05-14 |
2024-05-10 |
S
Sale
|
Avelar Rui
See Remarks
Officer
|
3,441
-0.9%
12.72
USD 43,761
|
3,441
-0.9%
|
12.72
|
USD 43,761
|
|
|
2024-03-29 |
2024-03-27 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
6,236
-0.9%
13.86
USD 86,431
|
6,236
-0.9%
|
13.86
|
USD 86,431
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
5,672
-3.5%
13.92
USD 78,978
|
5,672
-3.5%
|
13.92
|
USD 78,978
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
96,566
-12.2%
13.92
USD 1,344,604
|
96,566
-12.2%
|
13.92
|
USD 1,344,604
|
|
|
2024-03-21 |
2024-03-19 |
S
Sale
|
Avelar Rui
See Remarks
Officer
|
27,603
-6.9%
13.92
USD 384,350
|
27,603
-6.9%
|
13.92
|
USD 384,350
|
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
7,706
-1.0%
13.08
USD 100,804
|
7,706
-1.0%
|
13.08
|
USD 100,804
|
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
1,821
-1.1%
13.08
USD 23,821
|
1,821
-1.1%
|
13.08
|
USD 23,821
|
|
|
2024-02-23 |
2024-02-22 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
1,821
-0.5%
13.08
USD 23,821
|
1,821
-0.5%
|
13.08
|
USD 23,821
|
|
|
2024-02-02 |
2024-01-30 |
S
Sale
|
Parschauer Karah Herdman
Non-Executive Director
|
11,931
-27.6%
13.14
USD 156,733
|
11,931
-27.6%
|
13.14
|
USD 156,733
|
|
|
2023-12-08 |
2023-12-08 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
31,300
-4.9%
9.73
USD 304,505
|
31,300
-4.9%
|
9.73
|
USD 304,505
|
|
|
2023-12-08 |
2023-12-06 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
51,348
-7.5%
10.09
USD 517,891
|
51,348
-7.5%
|
10.09
|
USD 517,891
|
|
|
2023-10-18 |
2023-10-16 |
S
Sale
|
Medytox Inc.
|
1,690,663
-33.3%
7.50
USD 12,679,973
|
1,690,663
-33.3%
|
7.50
|
USD 12,679,973
|
|
|
2023-09-08 |
2023-09-06 |
PS
Planned sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
3,178
-2.7%
9.70
USD 30,827
|
3,178
-2.7%
|
9.70
|
USD 30,827
|
|
|
2023-08-16 |
2023-08-16 |
PS
Planned sale
|
Beaver Sandra
Chief Financial Officer
Officer
|
2,211
-1.9%
10.27
USD 22,707
|
2,211
-1.9%
|
10.27
|
USD 22,707
|
|
|
2023-08-16 |
2023-08-16 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
14,778
-2.1%
10.27
USD 151,770
|
14,778
-2.1%
|
10.27
|
USD 151,770
|
|
|
2023-08-16 |
2023-08-16 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
2,211
-0.6%
10.27
USD 22,707
|
2,211
-0.6%
|
10.27
|
USD 22,707
|
|
|
2023-08-15 |
2023-08-15 |
B
Purchase
|
Malik Vikram
Non-Executive Director
|
174,967
+174.0%
7.41
USD 1,296,505
|
174,967
+174.0%
|
7.41
|
USD 1,296,505
|
|
|
2023-03-29 |
2023-03-27 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
6,110
-1.0%
8.47
USD 51,752
|
6,110
-1.0%
|
8.47
|
USD 51,752
|
|
|
2023-03-16 |
2023-03-14 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
14,906
-4.2%
8.47
USD 126,237
|
14,906
-4.2%
|
8.47
|
USD 126,237
|
|
|
2023-03-16 |
2023-03-14 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
64,211
-9.4%
8.47
USD 543,797
|
64,211
-9.4%
|
8.47
|
USD 543,797
|
|
|
2023-02-08 |
2023-02-07 |
S
Sale
|
Medytox Inc.
Large shareholder
|
2,187,511
-30.1%
8.50
USD 18,593,844
|
2,187,511
-30.1%
|
8.50
|
USD 18,593,844
|
|
|
2023-02-06 |
2023-01-20 |
S
Sale
|
Medytox Inc.
Large shareholder
|
37,043
-0.5%
11.04
USD 408,955
|
37,043
-0.5%
|
11.04
|
USD 408,955
|
|
|
2022-10-07 |
2022-10-06 |
S
Sale
|
Medytox Inc.
Large shareholder
|
38,304
-0.5%
8.99
USD 344,418
|
38,304
-0.5%
|
8.99
|
USD 344,418
|
|
|
2022-10-06 |
2022-10-05 |
S
Sale
|
Medytox Inc.
Large shareholder
|
6,848
-0.1%
8.95
USD 61,290
|
6,848
-0.1%
|
8.95
|
USD 61,290
|
|
|
2022-09-16 |
2022-09-15 |
S
Sale
|
Medytox Inc.
Large shareholder
|
24,000
-0.3%
10.34
USD 248,105
|
24,000
-0.3%
|
10.34
|
USD 248,105
|
|
|
2022-09-16 |
2022-09-14 |
S
Sale
|
Medytox Inc.
Large shareholder
|
73,000
-1.0%
10.27
USD 749,674
|
73,000
-1.0%
|
10.27
|
USD 749,674
|
|
|
2022-09-13 |
2022-09-12 |
B
Purchase
|
HAYMAN ROBERT
Non-Executive Director
|
1,091
+12.2%
10.78
USD 11,756
|
1,091
+12.2%
|
10.78
|
USD 11,756
|
|
|
2022-09-13 |
2022-09-09 |
B
Purchase
|
HAYMAN ROBERT
Non-Executive Director
|
8,909
+inf%
10.35
USD 92,182
|
8,909
+inf%
|
10.35
|
USD 92,182
|
|
|
2022-09-12 |
2022-09-09 |
S
Sale
|
Medytox Inc.
Large shareholder
|
20,700
-0.3%
10.53
USD 217,911
|
20,700
-0.3%
|
10.53
|
USD 217,911
|
|
|
2022-09-12 |
2022-09-08 |
S
Sale
|
Medytox Inc.
Large shareholder
|
15,300
-0.2%
10.39
USD 158,979
|
15,300
-0.2%
|
10.39
|
USD 158,979
|
|
|
2022-09-09 |
2022-09-07 |
B
Purchase
|
HAYMAN ROBERT
Non-Executive Director
|
4,967
+14.2%
10.05
USD 49,918
|
4,967
+14.2%
|
10.05
|
USD 49,918
|
|
|
2022-09-08 |
2022-09-06 |
B
Purchase
|
BLANK SIMONE
Non-Executive Director
|
20,000
+57.3%
9.24
USD 184,844
|
20,000
+57.3%
|
9.24
|
USD 184,844
|
|
|
2022-09-06 |
2022-09-06 |
B
Purchase
|
FARRELL PETER C
Non-Executive Director
|
10,000
+inf%
9.10
USD 91,048
|
10,000
+inf%
|
9.10
|
USD 91,048
|
|
|
2022-08-03 |
2022-08-01 |
S
Sale
|
Medytox Inc.
Large shareholder
|
26,000
-0.3%
13.28
USD 345,361
|
26,000
-0.3%
|
13.28
|
USD 345,361
|
|
|
2022-05-18 |
2022-05-18 |
S
Sale
|
SILVERNAIL LAUREN P
See Remarks
Officer
|
52,015
-26.9%
12.42
USD 646,026
|
52,015
-26.9%
|
12.42
|
USD 646,026
|
|
|
2022-05-18 |
2022-05-17 |
S
Sale
|
SILVERNAIL LAUREN P
See Remarks
Officer
|
16,189
-7.7%
13.92
USD 225,354
|
16,189
-7.7%
|
13.92
|
USD 225,354
|
|
|
2022-05-18 |
2022-05-16 |
S
Sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
55,321
-10.1%
13.64
USD 754,307
|
55,321
-10.1%
|
13.64
|
USD 754,307
|
|
|
2022-05-17 |
2022-05-16 |
S
Sale
|
GILL DAVID N
Non-Executive Director
|
5,000
-14.5%
13.62
USD 68,080
|
5,000
-14.5%
|
13.62
|
USD 68,080
|
|
|
2022-05-17 |
2022-05-13 |
S
Sale
|
GILL DAVID N
Non-Executive Director
|
5,313
-13.3%
13.10
USD 69,584
|
5,313
-13.3%
|
13.10
|
USD 69,584
|
|
|
2022-03-30 |
2022-03-28 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
6,104
-1.1%
11.62
USD 70,928
|
6,104
-1.1%
|
11.62
|
USD 70,928
|
|
|
2022-03-10 |
2022-03-08 |
PS
Planned sale
|
Muilenburg Crystal
Chief Marketing Officer
Officer
|
6,495
-4.6%
9.73
USD 63,166
|
6,495
-4.6%
|
9.73
|
USD 63,166
|
|
|
2022-03-10 |
2022-03-08 |
PS
Planned sale
|
SILVERNAIL LAUREN P
See Remarks
Officer
|
10,192
-4.6%
9.73
USD 99,121
|
10,192
-4.6%
|
9.73
|
USD 99,121
|
|
|
2022-03-10 |
2022-03-08 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
10,192
-3.9%
9.73
USD 99,121
|
10,192
-3.9%
|
9.73
|
USD 99,121
|
|
|
2022-03-10 |
2022-03-08 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
37,972
-6.4%
9.73
USD 369,293
|
37,972
-6.4%
|
9.73
|
USD 369,293
|
|
|
2021-08-25 |
2021-08-24 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
72,219
+1.0%
11.17
USD 807,033
|
72,219
+1.0%
|
11.17
|
USD 807,033
|
|
|
2021-08-25 |
2021-08-23 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
69,781
+1.0%
11.03
USD 769,775
|
69,781
+1.0%
|
11.03
|
USD 769,775
|
|
|
2021-08-17 |
2021-08-16 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
65,000
+0.9%
11.34
USD 737,035
|
65,000
+0.9%
|
11.34
|
USD 737,035
|
|
|
2023-02-06 |
2021-08-13 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
14,043
+0.2%
11.11
USD 156,064
|
14,043
+0.2%
|
11.11
|
USD 156,064
|
|
|
2021-08-17 |
2021-08-13 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
49,714
+0.7%
10.98
USD 545,716
|
49,714
+0.7%
|
10.98
|
USD 545,716
|
|
|
2023-02-06 |
2021-08-12 |
B
Purchase
|
Medytox Inc.
Large shareholder
|
23,000
+0.3%
10.99
USD 252,775
|
23,000
+0.3%
|
10.99
|
USD 252,775
|
|
|
2021-01-26 |
2021-01-25 |
PS
Planned sale
|
SILVERNAIL LAUREN P
See Remarks
Officer
|
2,699
-2.9%
7.46
USD 20,135
|
2,699
-2.9%
|
7.46
|
USD 20,135
|
|
|
2021-01-26 |
2021-01-25 |
PS
Planned sale
|
Jafar Michael M.
See Remarks
Officer
|
2,699
-1.5%
7.46
USD 20,135
|
2,699
-1.5%
|
7.46
|
USD 20,135
|
|
|
2021-01-26 |
2021-01-25 |
PS
Planned sale
|
Avelar Rui
See Remarks
Officer
|
2,699
-2.0%
7.46
USD 20,135
|
2,699
-2.0%
|
7.46
|
USD 20,135
|
|
|
2021-01-26 |
2021-01-25 |
PS
Planned sale
|
MOATAZEDI DAVID
See Remarks
Executive Director
|
8,310
-4.6%
7.46
USD 61,993
|
8,310
-4.6%
|
7.46
|
USD 61,993
|
|
|
2020-01-08 |
2020-01-07 |
PS
Planned sale
|
Avelar Rui
See Remarks
|
39,442
-35.8%
10.71
USD 422,282
|
39,442
-35.8%
|
10.71
|
USD 422,282
|
|
